US 7943131
Methods for protecting and regenerating bone marrow using CXCR3 agonists and antagonists
granted A61KA61K31/00A61K31/255
Quick answer
US patent 7943131 (Methods for protecting and regenerating bone marrow using CXCR3 agonists and antagonists) held by GENERAL REGENERATIVES, LTD. expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- GENERAL REGENERATIVES, LTD.
- Grant date
- Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K31/00, A61K31/255, A61K31/437, A61K31/505